| 869 | 11 | 500 |
| 下载次数 | 被引频次 | 阅读次数 |
近年来，随着社会老龄化趋势日渐严重，围绝经期女性在我国女性人口占比逐渐增加，该阶段女性由于体内雌激素下降发生的肥胖、血脂异常、血糖异常等代谢相关的变化也逐渐引起社会的广泛关注。其中代谢综合征（metabolic syndrome,MS）严重威胁围绝经期女性的健康和生活质量。本文通过对围绝经期激素水平变化以及肥胖、高血脂、高血糖、高血压等代谢综合征危险因素进行分析讨论，阐述了围绝经期激素变化对代谢综合征危险因素的影响，以期通过识别高危因素，预防代谢综合征的发生、发展，降低代谢综合征相关不良事件的发生。
Abstract：In recent years, with the increasingly severe trend of an aging society, the proportion of perimenopausal women in China's female population is gradually increasing. Metabolic changes such as obesity, dyslipidemia, and glycemic abnormalities, which occur occur due to the decrease in estrogen during this stage, have also gradually attracted considerable attention from society. Among these, metabolic syndrome(MS) seriously threatens the health and quality of life of perimenopausal women. In this paper, the effects of perimenopausal hormonal changes on the risk factors of metabolic syndrome are discussed by analyzing the perimenopausal hormonal changes and the risk factors of metabolic syndrome such as obesity, hyperlipidemia, hyperglycemia, hypertension and so on. The aim is to prevent the occurrence and development of metabolic syndrome by identifying high-risk factors and to reduce the incidence of adverse events associated with metabolic syndrome.
[1]Alberti KG,Zimmet P,Shaw J,et al.The metabolic syndrome-a new worldwide definition[J].Lancet,2005,366(9491):1059-1062.
[2]Lu J,Wang L,Li M,et al.Metabolic Syndrome among adults in China:the 2010 China noncommunicable disease surveillance[J].J Clin Endocrinol Metab,2017,102(2):507-515.
[3]Song QB,Zhao Y,Liu YQ,et al.Sex difference in the prevalence of metabolic syndrome and cardiovascularrelated risk factors in urban adults from 33 communities of China:The CHPSNE study[J].Diab Vasc Dis Res,2015,12(3):189-198.
[4]Morales DD,Punzalan FE,Paz-Pacheco E,et al.Metabolic syndrome in the Philippine general population:prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus[J].Diab Vasc Dis Res,2008,5(1):36-43
[5]Ou YJ,Lee JI,Huang SP,et al.Association between menopause,postmenopausal hormone therapy and metabolic syndrome[J].J Clin Med,2023,12(13):4435.
[6]华克勤，丰有吉.实用妇产科学[M].北京：人民卫生出版社，2013.
[7]Li Y,Yu Q,Ma L,et al.Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city[J].Maturitas,2008,61(3):238-242.
[8]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel III)[J].JAMA,2001,285285:2486-2497.
[9]Jeong HG,Park H.Metabolic disorders in menopause[J].Metabolites,2022,12(10):954.
[10]中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中华糖尿病杂志，2004,12(3):156-161.
[11]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中国实用内科杂志，2018,38(4):292-344.
[12]Grundy SM,Cleeman JI,Daniels SR,et al.Diagnosis and management of the metabolic syndrome:an American heart association/national heart,lung,and blood institute scientific statement[J].Circulation,2005,112(17):2735-2752.
[13]陈妍春，杨洪喜，张馨予，等.中老年人群超重肥胖联合代谢综合征与心血管疾病发病风险的关联研究[J].中国慢性病预防与控制，2023,31(11):812-816,821.
[14]尹文卿，吴松宇，冯晓玲.围绝经期代谢综合征的风险分析及模型构建[J].中国妇幼健康研究，2023,34(3):48-53.
[15]Pan XF,Wang L,Pan A.Epidemiology and determinants of obesity in China[J].Lancet Diabetes Endocrinol,2021,9(6):373-392.
[16]陈春明.中国成人超重和肥胖症预防控制指南[M].北京：人民卫生出版社，2006:3.
[17]张思婷，张继国，贾小芳，等.2018年中国15省份18~65岁居民肥胖与2型糖尿病患病的关联研究[C]//中国营养学会第十五届全国营养科学大会.中国北京，2022:346.
[18]Yang L,Li L,Millwood IY,et al.Adiposity in relation to age at menarche and other reproductive factors among300 000 Chinese women:findings from China Kadoorie Biobank study[J].Int J Epidemiol,2017,46(2):502-512.
[19]Park CY,Lim JY,Park HY.Age at natural menopause in Koreans:secular trends and influences thereon[J].Menopause,2018,25(4):423-429.
[20]Li Y,Zhao D,Wang M,et al.Association between body mass index,waist circumference,and age at natural menopause:a population-based cohort study in Chinese women[J].Women Health,2021,61(9):902-913.
[21]Goh VHH,Hart WG.Excess fat in the abdomen but not general obesity is associated with poorer metabolic and cardiovascular health in premenopausal and postmenopausal Asian women[J].Maturitas,2018,107:33-38.
[22]Zhou Z,Moore TM,Drew BG,et al.Estrogen receptor αcontrols metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling[J].Sci Transl Med,2020,12(555):eaax8096.
[23]El Khoudary SR,Greendale G,Crawford SL,et al.The menopause transition and women’s health at midlife:a progress report from the Study of Women’s Health Across the Nation(SWAN)[J].Menopause,2019,26(10):1213-1227.
[24]Greendale GA,Sternfeld B,Huang M,et al.Changes in body composition and weight during the menopause transition[J].JCI insight,2019,4(5):e124865.
[25]周梦洁，张洁，李娜，等.人体成分与代谢综合征的相关性研究[J].西北国防医学杂志，2021,42(5):336-340.
[26]Lizcano F,Guzmán G.Estrogen deficiency and the origin of obesity during menopause[J].Biomed Res Int,2014,2014:757461.
[27]Nishimura K,Yoshino K,Ikeda N,et al.Oestrogendependent hypothalamic oxytocin expression with changes in feeding and body weight in female rats[J].Commun Biol,2022,5(1):912.
[28]李宇凤.围绝经期体内雄激素水平与脂肪分布的关联性研究[J].实用药物与临床，2016,19(11):1382-1385.
[29]Ko SH,Kim HS.Menopause-associated lipid metabolic disorders and foods beneficial for postmenopausal women[J].Nutrients,2020,12(1):202.
[30]Kapoor E,Kling JM,Lobo AS,et al.Menopausal hormone therapy in women with medical conditions[J].Best Pract Res Clin Endocrinol Metab,2021,35(6):101578.
[31]Marlatt KL,Pitynski-Miller DR,Gavin KM,et al.Body composition and cardiometabolic health across the menopause transition[J].Obesity(Silver Spring),2022,30(1):14-27.
[32]Farahmand M,Ramezani Tehrani F,Rahmati M,et al.Anthropometric indices and age at natural menopause:a15-year follow-up population-based study[J].Int JEndocrinol Metab,2021,19(4):e109285.
[33]Mastorakos G,Valsamakis G,Paltoglou G,et al.Management of obesity in menopause:diet,exercise,pharmacotherapy and bariatric surgery[J].Maturitas,2010,65(3):219-224.
[34]中华医学会妇产科学分会绝经学组.中国绝经管理与绝经激素治疗指南2023版[J].中华妇产科杂志，2023,58(1):4-21.
[35]诸骏仁，高润霖，赵水平，等.中国成人血脂异常防治指南（2016年修订版）[J].中国循环杂志，2016,31(10):937-953.
[36]Matthews KA,Crawford SL,Chae CU,et al.Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition?[J].J Am Coll Cardiol,2009,54(25):2366-2373.
[37]Anagnostis P,Stevenson JC,Crook D,et al.Effects of gender,age and menopausal status on serum apolipoprotein concentrations[J].Clin Endocrinol(Oxf),2016,85(5):733-740.
[38]Maas AHEM,Rosano G,Cifkova R,et al.Cardiovascular health after menopause transition,pregnancy disorders,and other gynaecologic conditions:a consensus document from European cardiologists,gynaecologists,and endocrinologists[J].Eur Heart J,2021,42(10):967-984.
[39]Qiu S,Vazquez JT,Boulger E,et al.Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in males[J].Sci Rep,2017,7(1):1661.
[40]蒋晨晨，杨欢欢，马庆华，等.苏州市老年女性性激素水平及雌激素受体基因多态性与血脂异常[J].卫生研究，2019,48(4):668-672.
[41]Guo Y,Zhao M,Bo T,et al.Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol[J].Cell Res,2019,29(2):151-166.
[42]Derby CA,Crawford SL,Pasternak RC,et al.Lipid changes during the menopause transition in relation to age and weight:the Study of Women’s Health Across the Nation[J].Am J Epidemiol,2009,169(11):1352-1361.
[43]Slopien R,Wender-Ozegowska E,Rogowicz-Frontczak A,et al.Menopause and diabetes:EMAS clinical guide[J].Maturitas,2018,117:6-10.
[44]黎庆凤，肖姿姿，刘海俊.雌激素受体对代谢综合征的影响研究进展[J].岭南急诊医学杂志，2022,27(4):402-403.
[45]Bryzgalova G,Gao H,Ahren B,et al.Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice:insulin sensitivity in the liver[J].Diabetologia,2006,49(3):588-597.
[46]Cheng Y,Zhu H,Ren J,et al.Follicle-stimulating hormone orchestrates glucose-stimulated insulin secretion of pancreatic islets[J].Nat Commun,2023,14(1):6991.
[47]常鑫，赵楠，汤旭磊.绝经因素与代谢综合征相关性的研究进展[J].医学研究杂志，2019,48(12):14-16,64.
[48]苏红，包宇航，郑仁东，等.女性性激素与糖代谢关系的研究进展[J].临床医学研究与实践，2022,7(21):196-198.
[49]Kannel WB,Hjortland MC,McNamara PM,et al.Menopause and risk of cardiovascular disease:the Framingham study[J].Ann Intern Med,1976,85(4):447-452.
[50]杨学涛，周亮，刘方洲，等.高血压发病的性别差异及机制[J].中华高血压杂志，2019,27(4):327-334.
[51]Coylewright M,Reckelhoff JF,Ouyang P.Menopause and hypertension:an age-old debate[J].Hypertension,2008,51(4):952-959.
[52]Guivarc’h E,Favre J,Guihot AL,et al.Nuclear activation function 2 estrogen receptor α attenuates arterial and renal alterations due to aging and hypertension in female mice[J].J Am Heart Assoc,2020,9(5):e013895.
[53]孟犁南.激素替代治疗联合降压药物对围绝经期原发性高血压女性血压及内皮功能的影响[J].中国妇幼保健，2016,31(1):193-194.
基本信息:
DOI：10.19757/j.cnki.issn1674-7763.2024.05.011
中图分类号:R711.75;R589
引用信息:
[1]马彦菁,顾燕芳.围绝经期与代谢综合征的相关性研究现况[J].中国妇幼卫生杂志,2024,15(05):60-66.DOI:10.19757/j.cnki.issn1674-7763.2024.05.011.
2024-10-20
2024-10-20